HIV prevention: better choice for better coverage
Antiretroviral-based pre-exposure prophylaxis (PrEP) is today an established, effective and safe method of HIV prevention used in multiple countries worldwide by a broad range of populations at risk of HIV infection. Biomedical innovations are critical in supporting the primary prevention of HIV; however, their potential can only be maximized if end-user challenges are recognized, described and used to develop next-generation models. This commentary concludes that, in order to ensure that all people have access to prevention options that meet their specific prevention needs, both early and next-generation PrEP options are needed.
January 2022
Click for full info +Full Info:
Resource Type:
Citation:
Antiretroviral-based pre-exposure prophylaxis (PrEP) is today an established, effective and safe method of HIV prevention used in multiple countries worldwide by a broad range of populations at risk of HIV infection. Biomedical innovations are critical in supporting the primary prevention of HIV; however, their potential can only be maximized if end-user challenges are recognized, described and used to develop next-generation models.
Authors:
Bekker, Linda-Gail; Pike, Carey; & Hillier, Sharon L.
Health Risks(s):
- HIV
Product type(s):
- ARVs
Topic(s):
- Product Introduction
- Social
Region(s)
- Africa
- Global